• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[免疫检查点抑制剂相关的不良事件:内科医生/全科医生的观点]

[Immune-related adverse events of checkpoint inhibitors: an internist/general practitioner's point of view].

作者信息

Cisarovsky Christophe, Kraege Vanessa, Obeid Michel, Garnier Antoine

机构信息

Service de médecine interne, Département de médecine interne, CHUV, 1011 Lausanne.

Service d'immunologie et allergie, Département de médecine interne, CHUV, 1011 Lausanne.

出版信息

Rev Med Suisse. 2020 Nov 25;16(716):2264-2270.

PMID:33237644
Abstract

Immune checkpoint inhibitors have radically changed oncology by significantly improving prognosis and survival of many patients, even at an advanced or metastatic stage. Some patients undergoing immunotherapy develop adverse immune-related events, presenting a toxicity spectrum that can affect any organ, separately or simultaneously, with different intensities depending on the treatment used and patient characteristics. We hereby suggest a diagnostic and therapeutic approach that any internist, general practitioner or emergency doctor should have facing digestive, cardiac and pulmonary toxicities.

摘要

免疫检查点抑制剂已彻底改变了肿瘤学,显著改善了许多患者的预后和生存率,即使是在晚期或转移阶段。一些接受免疫治疗的患者会出现不良免疫相关事件,其毒性谱可单独或同时影响任何器官,毒性强度因所使用的治疗方法和患者特征而异。在此,我们提出一种诊断和治疗方法,任何内科医生、全科医生或急诊医生在面对消化、心脏和肺部毒性时都应掌握。

相似文献

1
[Immune-related adverse events of checkpoint inhibitors: an internist/general practitioner's point of view].[免疫检查点抑制剂相关的不良事件:内科医生/全科医生的观点]
Rev Med Suisse. 2020 Nov 25;16(716):2264-2270.
2
Immunotherapy Toxicities.免疫疗法的毒性反应。
Surg Oncol Clin N Am. 2019 Jul;28(3):387-401. doi: 10.1016/j.soc.2019.02.009. Epub 2019 Apr 5.
3
[Autoimmune side effects of immune-checkpoint inhibitor therapies in oncology: pathogenesis, clinic and treatment].[肿瘤免疫检查点抑制剂疗法的自身免疫性副作用:发病机制、临床与治疗]
Orv Hetil. 2019 Jun;160(23):887-895. doi: 10.1556/650.2019.31392.
4
Characteristics of hospitalizations among patients receiving immune checkpoint inhibitors at a community teaching hospital.一家社区教学医院中接受免疫检查点抑制剂治疗患者的住院特征。
J Oncol Pharm Pract. 2020 Jan;26(1):60-66. doi: 10.1177/1078155219836155. Epub 2019 Mar 29.
5
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019).SEOM 临床指南:免疫检查点抑制剂治疗患者免疫相关不良事件的管理(2019 年)。
Clin Transl Oncol. 2020 Feb;22(2):213-222. doi: 10.1007/s12094-019-02273-x. Epub 2020 Jan 28.
6
Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians.免疫检查点抑制剂毒性的管理:急诊医师综述与临床指南
J Emerg Med. 2018 Oct;55(4):489-502. doi: 10.1016/j.jemermed.2018.07.005. Epub 2018 Aug 16.
7
Immune-related adverse events with immune checkpoint blockade: a comprehensive review.免疫检查点阻断相关的免疫相关不良事件:一项全面综述。
Eur J Cancer. 2016 Feb;54:139-148. doi: 10.1016/j.ejca.2015.11.016. Epub 2016 Jan 5.
8
[Toxicities of immune checkpoint inhibitors and their management].免疫检查点抑制剂的毒性及其管理
Med Sci (Paris). 2019 Dec;35(12):949-956. doi: 10.1051/medsci/2019191. Epub 2020 Jan 6.
9
Management of immune checkpoint inhibitor-related dermatologic adverse events.免疫检查点抑制剂相关皮肤不良反应的管理。
Thorac Cancer. 2020 Feb;11(2):488-492. doi: 10.1111/1759-7714.13275. Epub 2019 Dec 9.
10
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials.评估早期免疫治疗试验中剂量限制毒性的延迟免疫相关不良事件。
Eur J Cancer. 2019 Jan;107:1-7. doi: 10.1016/j.ejca.2018.10.017. Epub 2018 Dec 7.